نتایج جستجو برای: revaccination

تعداد نتایج: 453  

2016
Carlos A. DiazGranados Andrew J. Dunning Corwin A. Robertson H. Keipp Talbot Victoria Landolfi David P. Greenberg

BACKGROUND High-dose inactivated influenza vaccine (IIV-HD) is an alternative to the standard-dose inactivated influenza vaccine (IIV-SD) in the United States for influenza prevention in older adults. IIV-HD improved efficacy relative to IIV-SD in a randomized controlled trial. Recent observational studies suggest that previous influenza vaccination may influence the immunogenicity and effectiv...

Journal: :Clinical and vaccine immunology : CVI 2007
Meng Chen Yuki Hisatomi Akitsugu Furumoto Kenji Kawakami Hironori Masaki Tsuyoshi Nagatake Yoshiko Sueyasu Tomoaki Iwanaga Hisamichi Aizawa Kazunori Oishi

Antibody responses to a 23-valent pneumococcal vaccine for Streptococcus pneumoniae serotypes 6B, 14, 19F, and 23F in 84 patients with chronic pulmonary diseases over a 2-year period after vaccination were examined by using a third-generation enzyme-linked immunosorbent assay. Of these patients, 28 (31%) were low responders who had developed increases of at least twofold in the levels of seroty...

Journal: :Jornal de pediatria 2006
Mauricio L Barreto Susan M Pereira Arlan A Ferreira

OBJECTIVES To review the protective efficacy of the first and second doses of BCG vaccine and to assess its major indications and contraindications. SOURCES OF DATA A systematic review of the literature was made by searching PubMed and selecting studies carried out in the last 50 years. The studies were grouped according to their design (clinical trials, case-control studies, and meta-analyse...

ژورنال: Vaccine Research 2017

Tuberculosis (TB) is one of the most important public health problems in the world and has been declared as a global emergency by the World Health Organization (WHO) in 1993. Bacillus Calmette-Guérin (BCG) is one of the first developed vaccines to prevent TB. Unfortunately, BCG vaccine has had a limited duration of protection and has shown controversial and variable levels of efficacy, especial...

Journal: :Clinical and vaccine immunology : CVI 2011
Jose A Serpa Josemon Valayam Daniel M Musher Roger D Rossen Liise-anne Pirofski Maria C Rodriguez-Barradas

Pneumococcal disease continues to cause substantial morbidity and mortality among the elderly. Older adults may have high levels of anticapsular antibody after vaccination, but their antibodies show decreased functional activity. In addition, the protective effect of the pneumococcal polysaccharide vaccine (PPV) seems to cease as early as 3 to 5 years postvaccination. Recently, it was suggested...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید